Top compounds associated with response to AFTPH


Feature Type Standardized
Nominal ANOVA
mRNA EHT 1864 GDSC1000 pan-cancer AAC -0.075 0.06
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.06
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.1 0.06
mRNA Compound 1541A CTRPv2 pan-cancer AAC 0.08 0.06
mRNA PHA-665752 GDSC1000 pan-cancer AAC -0.11 0.06
mRNA staurosporine CTRPv2 pan-cancer AAC -0.15 0.06
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.076 0.06
mRNA SN-38 GDSC1000 pan-cancer AAC -0.072 0.06
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.075 0.06
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.075 0.06
Download CSV